Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
443.54
+2.67 (0.61%)
At close: Jun 23, 2025, 4:00 PM
443.54
0.00 (0.00%)
After-hours: Jun 23, 2025, 4:06 PM EDT
Vertex Pharmaceuticals Analyst Ratings
Total Analysts
26
Consensus Rating
Buy
Price Target
$510.48
Upside
+15.09%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $550 | Strong Buy | Reiterates | $550 | +24.00% | Jun 23, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $464 → $460 | Hold | Maintains | $464 → $460 | +3.71% | Jun 20, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $423 → $420 | Hold | Maintains | $423 → $420 | -5.31% | Jun 17, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $420 → $423 | Hold | Maintains | $420 → $423 | -4.63% | May 6, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $450 → $442 | Hold | Maintains | $450 → $442 | -0.35% | May 6, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $462 → $464 | Hold | Maintains | $462 → $464 | +4.61% | May 6, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $512 → $515 | Buy | Maintains | $512 → $515 | +16.11% | May 6, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $535 | Buy | Reiterates | $535 | +20.62% | May 6, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 6, 2025 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $550 → $503 | Buy → Hold | Downgrades | $550 → $503 | +13.41% | May 6, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $535 | Buy | Initiates | $535 | +20.62% | Apr 22, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $408 → $420 | Hold | Maintains | $408 → $420 | -5.31% | Apr 1, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $555 → $567 | Strong Buy | Maintains | $555 → $567 | +27.84% | Mar 31, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $407 → $408 | Hold | Maintains | $407 → $408 | -8.01% | Feb 20, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Sell → Hold Upgrades $408 → $424 | Strong Sell → Hold | Upgrades | $408 → $424 | -4.41% | Feb 12, 2025 |
| UBS | UBS | Strong Buy Maintains $586 → $583 | Strong Buy | Maintains | $586 → $583 | +31.44% | Feb 11, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.